Results · Apr-Jun 2026
Kimia Biosciences Q1 FY27 results
Sales fell 12% to ₹20.7 crore from ₹23.6 crore in Apr-Jun 2025.
Operating profit fell 7% to ₹2.3 crore, an operating margin of 11.3% (up 0.6 points from a year ago).
Net profit fell 41% to ₹0.36 crore from ₹0.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −24%, net profit −5%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 20.7 | 23.6 | −12% |
| Operating profit (EBITDA) | 2.3 | 2.5 | −7% |
| Operating margin | 11.3% | 10.7% | +0.6 pts |
| Net profit | 0.4 | 0.6 | −41% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.